- Home
- ALHC
as 07-26-2024 4:00pm EST
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
Upcoming Earnings Alert:
Get ready for potential market movements as Alignment Healthcare Inc. ALHC prepares to release earnings report on 01 Aug 2024.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | ORANGE |
| Market Cap: | 1.6B | IPO Year: | 2021 |
| Target Price: | $8.69 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.84 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.46 - $10.16 | Next Earning Date: | 08-01-2024 |
| Revenue: | $2,013,076,000 | Revenue Growth: | 31.76% |
| Revenue Growth (this year): | 15.76% | Revenue Growth (next year): | 21.89% |
Stock Insider Trading Activity of Alignment Healthcare Inc. (ALHC)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| KONOWIECKI JOSEPH S | ALHC | Director | Jul 17 '24 | Sell | $10.01 | 100 | $1,001.00 | 1,208,221 | SEC Form 4 |
| KONOWIECKI JOSEPH S | ALHC | Director | Jul 17 '24 | Sell | $10.00 | 24,900 | $249,000.00 | 1,208,321 | SEC Form 4 |
| MARGOLIS JEFFREY H | ALHC | Director | Jul 15 '24 | Sell | $8.94 | 1,200 | $10,728.00 | 414,733 | SEC Form 4 |
| KONOWIECKI JOSEPH S | ALHC | Chairman of the Board | Jul 12 '24 | Sell | $9.06 | 22,400 | $203,035.84 | 1,233,221 | SEC Form 4 |
| KONOWIECKI JOSEPH S | ALHC | Chairman of the Board | Jul 12 '24 | Sell | $9.00 | 2,600 | $23,402.60 | 1,255,621 | SEC Form 4 |
| JOYCE CHRISTOPHER J | ALHC | Chief Legal and Admin. Officer | Jul 1 '24 | Sell | $8.00 | 666 | $5,328.00 | 422,246 | SEC Form 4 |
| JOYCE CHRISTOPHER J | ALHC | Chief Legal and Admin. Officer | Jun 14 '24 | Sell | $8.01 | 16,000 | $128,198.40 | 422,912 | SEC Form 4 |
| MARGOLIS JEFFREY H | ALHC | Director | Jun 14 '24 | Sell | $8.06 | 1,200 | $9,672.00 | 415,933 | SEC Form 4 |
| Maroney Dawn Christine | ALHC | President, Markets | Jun 12 '24 | Sell | $8.21 | 20,000 | $164,200.00 | 1,956,097 | SEC Form 4 |
| Freeman Robert Thomas | ALHC | Chief Financial Officer | Mar 28 '24 | Sell | $4.84 | 4,299 | $20,807.16 | 865,407 | SEC Form 4 |
| Scavo Robert L. | ALHC | Chief Information Officer | Mar 28 '24 | Sell | $4.84 | 1,821 | $8,813.64 | 436,822 | SEC Form 4 |
| Maroney Dawn Christine | ALHC | President, Markets | Mar 28 '24 | Sell | $4.84 | 10,151 | $49,130.84 | 1,976,097 | SEC Form 4 |
| Kardes Hakan | ALHC | Chief Experience Officer | Mar 28 '24 | Sell | $4.84 | 4,363 | $21,116.92 | 430,444 | SEC Form 4 |
| Scavo Robert L. | ALHC | Chief Information Officer | Mar 19 '24 | Sell | $5.05 | 3,078 | $15,546.36 | 438,643 | SEC Form 4 |
| Kardes Hakan | ALHC | Chief Experience Officer | Mar 19 '24 | Sell | $5.05 | 18,964 | $95,783.37 | 434,807 | SEC Form 4 |
| Maroney Dawn Christine | ALHC | President, Markets | Mar 19 '24 | Sell | $5.05 | 15,861 | $80,110.74 | 1,999,500 | SEC Form 4 |
| Maroney Dawn Christine | ALHC | President, Markets | Mar 19 '24 | Sell | $4.83 | 13,252 | $64,007.16 | 1,986,248 | SEC Form 4 |
| Kim Hyong | ALHC | Chief Medical Officer | Mar 19 '24 | Sell | $5.05 | 5,576 | $28,163.26 | 555,530 | SEC Form 4 |
| Freeman Robert Thomas | ALHC | Chief Financial Officer | Mar 19 '24 | Sell | $5.05 | 28,522 | $144,058.92 | 869,706 | SEC Form 4 |
| JOYCE CHRISTOPHER J | ALHC | Chief Legal and Admin. Officer | Mar 19 '24 | Sell | $5.05 | 25,060 | $126,573.05 | 438,912 | SEC Form 4 |
| KAO JOHN E | ALHC | Chief Executive Officer | Mar 14 '24 | Buy | $4.82 | 103,000 | $496,779.30 | 2,745,253 | SEC Form 4 |
| Kardes Hakan | ALHC | Chief Experience Officer | Mar 13 '24 | Sell | $4.89 | 4,326 | $21,158.90 | 453,771 | SEC Form 4 |
| Maroney Dawn Christine | ALHC | President, Markets | Mar 13 '24 | Sell | $4.89 | 21,537 | $105,339.62 | 2,015,361 | SEC Form 4 |
| Freeman Robert Thomas | ALHC | Chief Financial Officer | Mar 13 '24 | Sell | $4.89 | 11,858 | $57,998.66 | 898,228 | SEC Form 4 |
| Scavo Robert L. | ALHC | Chief Information Officer | Mar 13 '24 | Sell | $4.89 | 4,852 | $23,731.62 | 441,721 | SEC Form 4 |
Latest Alignment Healthcare Inc. News
ALHC Breaking Stock News: Dive into ALHC Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
Calculating The Fair Value Of Alignment Healthcare, Inc. (NASDAQ:ALHC)
MT Newswires
5 days ago
Alignment Healthcare Insider Sold Shares Worth $1,050,236, According to a Recent SEC Filing
GuruFocus.com
7 days ago
Insider Sale: Director Joseph Konowiecki Sells 25,000 Shares of Alignment Healthcare Inc (ALHC)
GuruFocus.com
7 days ago
Insider Sale: President of Markets Dawn Maroney Sells 100,000 Shares of Alignment Healthcare ...
GuruFocus.com
8 days ago
Insider Sale: Chief Experience Officer Hakan Kardes Sells 25,000 Shares of Alignment Healthcare ...
GuruFocus.com
10 days ago
Insider Sale: Christopher Joyce Sells 15,334 Shares of Alignment Healthcare Inc (ALHC)
Zacks
14 days ago
Alignment Healthcare (ALHC) Surges 11.5%: Is This an Indication of Further Gains?
GlobeNewswire
15 days ago
Alignment Healthcare to Announce Second Quarter 2024 Financial Results and Host Conference Call Thursday, Aug. 1, 2024
Compare ALHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALHC Alignment Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.